Katie Robinson

News

Physicians may be overprescribing immunotherapy for unfit cancer patients

Author:: Katie Robinson

Publish date: December 7, 2021

Study suggests the benefits from ICI therapy may not translate to patients who are traditionally excluded from phase 3 trials.

News

Three drugs go head-to-head in advanced lung cancer study

Author:: Katie Robinson

Publish date: November 29, 2021

This is the first-known analysis that compares atezolizumab, nivolumab, and docetaxel in patients outside of clinical trials. Atezolizumab and nivo...

News

MRI before tongue carcinoma biopsy may be more reliable than other radiologic methods

Author:: Katie Robinson

Publish date: November 24, 2021

Getting an accurate measure of the depth of a tongue squamous cell carcinoma is critical to determining a patient’s prognosis. But which radiologic...

News

Common lung cancer screening tool superior to alternatives

Author:: Katie Robinson

Publish date: November 19, 2021

CT scans are increasingly used for lung cancer screening, so accuracy is essential in devising an appropriate treatment plan for patients.

News

Exercise reduces arm and shoulder problems after breast cancer surgery

Author:: Katie Robinson

Publish date: November 16, 2021

Study provides the best quality evidence to date in support of early exercise for women at high risk of shoulder problems after breast cancer treat...

News

Dogs show potential as medical detectives in breast cancer

Author:: Katie Robinson

Publish date: November 5, 2021

First preliminary study indicating the feasibility of developing a new breast cancer screening method using urine samples based on volatile organic...

News

Overall survival for metastatic urothelial carcinoma approaching 2 years

Author:: Katie Robinson

Publish date: November 2, 2021

Metastatic urothelial carcinoma is still a hard-to-treat condition with a 12- to 15-month survival for metastatic disease that is treated. In a new...

News

Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomes

Author:: Katie Robinson

Publish date: October 28, 2021

Observational study finds that antibiotics and glucocorticoids at 10 mg daily when given within 1 month before or after immune checkpoint inhibitor...

News

Uncertainty looms large in treatment options for high-risk cutaneous SCC

Author:: Katie Robinson

Publish date: October 28, 2021

More data – and high-quality data – are needed for physicians to determine with more confidence which adjuvant therapies would be best for specific...

News

Lung cancer screening rates in U.S. nowhere near goal

Author:: Katie Robinson

Publish date: October 28, 2021

Lung cancer screening is effective in reducing mortality, particularly when patients adhere to follow-up recommendations, but too few patients in t...

News

Immunocompromised people face highest risk of cutaneous SCC metastasis

Author:: Katie Robinson

Publish date: October 28, 2021

Immunocompromised individuals, such as solid organ transplant patients, make up 73.3% of all patients with cutaneous SCC who are at risk of metasta...

News

Early mortality falls in advanced ovarian cancer with neoadjuvant chemo

Author:: Katie Robinson

Publish date: October 19, 2021

This observational study shows reductions in early mortality for patients with advanced ovarian cancer. The findings may inform treatment decisions...

News

Donafenib shows potential as first-line treatment of advanced hepatocellular carcinoma

Author:: Katie Robinson

Publish date: October 19, 2021

Donafenib is newly approved in China. It may emerge as a new first-in-line treatment for advanced HCC in China, filling a treatment gap.

News

Neuroimaging may predict cognitive decline after chemotherapy for breast cancer

Author:: Katie Robinson

Publish date: October 19, 2021

Cognitive decline after chemotherapy has been reported in 20%-40% of patients with cancer. Now, researchers say they have identified a measurement ...

News

Priming tremelimumab dose regimen shows promising benefit-risk profile in HCC

Author:: Katie Robinson

Publish date: October 19, 2021

Immunotherapies provide durable, long-term survival leading to substantial survival tails in the Kaplan-Meier OS curves associated with anti–CTLA-4...